Prodrugs based on phospholipid-nucleoside conjugates
US4471113A · kind A · utility
36Cited by
2References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 3, 1982 |
| Grant date | Sep 11, 1984 |
| Priority date | — |
| Expiry date | Feb 3, 2002 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to the production of a single diastereomeric form of a phospholipid araC conjugate as a prodrug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.